COVID-19 Impact on Global Skin Disease Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 92 pages | ID: C130CAA2C09CEN
QYResearch

Abstracts

This report focuses on the global Skin Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Skin Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• APEIRON Biologics AG
• HanAll BioPharma
• GlaxoSmithKline plc.
• Allergen, Plc.
• Anacor Pharmaceuticals
• Celgene
• Basilea Pharmaceutica
• Cipher Pharmaceuticals
• Agenus
• Astion Pharma A/S
• Bristol-Myers Squibb
• Almirall S.A.
• Galderma

Market segment by Type, the product can be split into

• Medicated Creams and Ointments
• Antibiotics
• Vitamins and Steroids
• Antihistamines
• Laser Therapy
• Antifungals
• Others

Market segment by Application, split into

• Dermatology Clinics
• Skincare Clinics
• Hospitals
• Aesthetic Centers
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Skin Disease Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Skin Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Skin Disease Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Skin Disease Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Skin Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Medicated Creams and Ointments
  1.4.3 Antibiotics
  1.4.4 Vitamins and Steroids
  1.4.5 Antihistamines
  1.4.6 Laser Therapy
  1.4.7 Antifungals
  1.4.8 Others
1.5 Market by Application
  1.5.1 Global Skin Disease Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Dermatology Clinics
  1.5.3 Skincare Clinics
  1.5.4 Hospitals
  1.5.5 Aesthetic Centers
  1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Skin Disease Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Skin Disease Treatment Industry
    1.6.1.1 Skin Disease Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Skin Disease Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Skin Disease Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Skin Disease Treatment Market Perspective (2015-2026)
2.2 Skin Disease Treatment Growth Trends by Regions
  2.2.1 Skin Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Skin Disease Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Skin Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Skin Disease Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Skin Disease Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Skin Disease Treatment Players by Market Size
  3.1.1 Global Top Skin Disease Treatment Players by Revenue (2015-2020)
  3.1.2 Global Skin Disease Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Skin Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Skin Disease Treatment Market Concentration Ratio
  3.2.1 Global Skin Disease Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Skin Disease Treatment Revenue in 2019
3.3 Skin Disease Treatment Key Players Head office and Area Served
3.4 Key Players Skin Disease Treatment Product Solution and Service
3.5 Date of Enter into Skin Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Skin Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Skin Disease Treatment Forecasted Market Size by Type (2021-2026)

5 SKIN DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Skin Disease Treatment Market Size by Application (2015-2020)
5.2 Global Skin Disease Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Skin Disease Treatment Market Size (2015-2020)
6.2 Skin Disease Treatment Key Players in North America (2019-2020)
6.3 North America Skin Disease Treatment Market Size by Type (2015-2020)
6.4 North America Skin Disease Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Skin Disease Treatment Market Size (2015-2020)
7.2 Skin Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Skin Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Skin Disease Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Skin Disease Treatment Market Size (2015-2020)
8.2 Skin Disease Treatment Key Players in China (2019-2020)
8.3 China Skin Disease Treatment Market Size by Type (2015-2020)
8.4 China Skin Disease Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Skin Disease Treatment Market Size (2015-2020)
9.2 Skin Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Skin Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Skin Disease Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Skin Disease Treatment Market Size (2015-2020)
10.2 Skin Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Skin Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Skin Disease Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Skin Disease Treatment Market Size (2015-2020)
11.2 Skin Disease Treatment Key Players in India (2019-2020)
11.3 India Skin Disease Treatment Market Size by Type (2015-2020)
11.4 India Skin Disease Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Skin Disease Treatment Market Size (2015-2020)
12.2 Skin Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Skin Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Skin Disease Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 APEIRON Biologics AG
  13.1.1 APEIRON Biologics AG Company Details
  13.1.2 APEIRON Biologics AG Business Overview and Its Total Revenue
  13.1.3 APEIRON Biologics AG Skin Disease Treatment Introduction
  13.1.4 APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2015-2020))
  13.1.5 APEIRON Biologics AG Recent Development
13.2 HanAll BioPharma
  13.2.1 HanAll BioPharma Company Details
  13.2.2 HanAll BioPharma Business Overview and Its Total Revenue
  13.2.3 HanAll BioPharma Skin Disease Treatment Introduction
  13.2.4 HanAll BioPharma Revenue in Skin Disease Treatment Business (2015-2020)
  13.2.5 HanAll BioPharma Recent Development
13.3 GlaxoSmithKline plc.
  13.3.1 GlaxoSmithKline plc. Company Details
  13.3.2 GlaxoSmithKline plc. Business Overview and Its Total Revenue
  13.3.3 GlaxoSmithKline plc. Skin Disease Treatment Introduction
  13.3.4 GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2015-2020)
  13.3.5 GlaxoSmithKline plc. Recent Development
13.4 Allergen, Plc.
  13.4.1 Allergen, Plc. Company Details
  13.4.2 Allergen, Plc. Business Overview and Its Total Revenue
  13.4.3 Allergen, Plc. Skin Disease Treatment Introduction
  13.4.4 Allergen, Plc. Revenue in Skin Disease Treatment Business (2015-2020)
  13.4.5 Allergen, Plc. Recent Development
13.5 Anacor Pharmaceuticals
  13.5.1 Anacor Pharmaceuticals Company Details
  13.5.2 Anacor Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Anacor Pharmaceuticals Skin Disease Treatment Introduction
  13.5.4 Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2015-2020)
  13.5.5 Anacor Pharmaceuticals Recent Development
13.6 Celgene
  13.6.1 Celgene Company Details
  13.6.2 Celgene Business Overview and Its Total Revenue
  13.6.3 Celgene Skin Disease Treatment Introduction
  13.6.4 Celgene Revenue in Skin Disease Treatment Business (2015-2020)
  13.6.5 Celgene Recent Development
13.7 Basilea Pharmaceutica
  13.7.1 Basilea Pharmaceutica Company Details
  13.7.2 Basilea Pharmaceutica Business Overview and Its Total Revenue
  13.7.3 Basilea Pharmaceutica Skin Disease Treatment Introduction
  13.7.4 Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2015-2020)
  13.7.5 Basilea Pharmaceutica Recent Development
13.8 Cipher Pharmaceuticals
  13.8.1 Cipher Pharmaceuticals Company Details
  13.8.2 Cipher Pharmaceuticals Business Overview and Its Total Revenue
  13.8.3 Cipher Pharmaceuticals Skin Disease Treatment Introduction
  13.8.4 Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2015-2020)
  13.8.5 Cipher Pharmaceuticals Recent Development
13.9 Agenus
  13.9.1 Agenus Company Details
  13.9.2 Agenus Business Overview and Its Total Revenue
  13.9.3 Agenus Skin Disease Treatment Introduction
  13.9.4 Agenus Revenue in Skin Disease Treatment Business (2015-2020)
  13.9.5 Agenus Recent Development
13.10 Astion Pharma A/S
  13.10.1 Astion Pharma A/S Company Details
  13.10.2 Astion Pharma A/S Business Overview and Its Total Revenue
  13.10.3 Astion Pharma A/S Skin Disease Treatment Introduction
  13.10.4 Astion Pharma A/S Revenue in Skin Disease Treatment Business (2015-2020)
  13.10.5 Astion Pharma A/S Recent Development
13.11 Bristol-Myers Squibb
  10.11.1 Bristol-Myers Squibb Company Details
  10.11.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  10.11.3 Bristol-Myers Squibb Skin Disease Treatment Introduction
  10.11.4 Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2015-2020)
  10.11.5 Bristol-Myers Squibb Recent Development
13.12 Almirall S.A.
  10.12.1 Almirall S.A. Company Details
  10.12.2 Almirall S.A. Business Overview and Its Total Revenue
  10.12.3 Almirall S.A. Skin Disease Treatment Introduction
  10.12.4 Almirall S.A. Revenue in Skin Disease Treatment Business (2015-2020)
  10.12.5 Almirall S.A. Recent Development
13.13 Galderma
  10.13.1 Galderma Company Details
  10.13.2 Galderma Business Overview and Its Total Revenue
  10.13.3 Galderma Skin Disease Treatment Introduction
  10.13.4 Galderma Revenue in Skin Disease Treatment Business (2015-2020)
  10.13.5 Galderma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Skin Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Skin Disease Treatment Revenue
Table 3. Ranking of Global Top Skin Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Skin Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medicated Creams and Ointments
Table 6. Key Players of Antibiotics
Table 7. Key Players of Vitamins and Steroids
Table 8. Key Players of Antihistamines
Table 9. Key Players of Laser Therapy
Table 10. Key Players of Antifungals
Table 11. Key Players of Others
Table 12. COVID-19 Impact Global Market: (Four Skin Disease Treatment Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Skin Disease Treatment Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Skin Disease Treatment Players to Combat Covid-19 Impact
Table 17. Global Skin Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Skin Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Skin Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Skin Disease Treatment Market Share by Regions (2015-2020)
Table 21. Global Skin Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Skin Disease Treatment Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Skin Disease Treatment Market Growth Strategy
Table 27. Main Points Interviewed from Key Skin Disease Treatment Players
Table 28. Global Skin Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 29. Global Skin Disease Treatment Market Share by Players (2015-2020)
Table 30. Global Top Skin Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Disease Treatment as of 2019)
Table 31. Global Skin Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Skin Disease Treatment Product Solution and Service
Table 34. Date of Enter into Skin Disease Treatment Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Skin Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. Global Skin Disease Treatment Market Size Share by Type (2015-2020)
Table 38. Global Skin Disease Treatment Revenue Market Share by Type (2021-2026)
Table 39. Global Skin Disease Treatment Market Size Share by Application (2015-2020)
Table 40. Global Skin Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. Global Skin Disease Treatment Market Size Share by Application (2021-2026)
Table 42. North America Key Players Skin Disease Treatment Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Skin Disease Treatment Market Share (2019-2020)
Table 44. North America Skin Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. North America Skin Disease Treatment Market Share by Type (2015-2020)
Table 46. North America Skin Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. North America Skin Disease Treatment Market Share by Application (2015-2020)
Table 48. Europe Key Players Skin Disease Treatment Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Skin Disease Treatment Market Share (2019-2020)
Table 50. Europe Skin Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Skin Disease Treatment Market Share by Type (2015-2020)
Table 52. Europe Skin Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Skin Disease Treatment Market Share by Application (2015-2020)
Table 54. China Key Players Skin Disease Treatment Revenue (2019-2020) (Million US$)
Table 55. China Key Players Skin Disease Treatment Market Share (2019-2020)
Table 56. China Skin Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. China Skin Disease Treatment Market Share by Type (2015-2020)
Table 58. China Skin Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. China Skin Disease Treatment Market Share by Application (2015-2020)
Table 60. Japan Key Players Skin Disease Treatment Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Skin Disease Treatment Market Share (2019-2020)
Table 62. Japan Skin Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Skin Disease Treatment Market Share by Type (2015-2020)
Table 64. Japan Skin Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Skin Disease Treatment Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Skin Disease Treatment Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Skin Disease Treatment Market Share (2019-2020)
Table 68. Southeast Asia Skin Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Skin Disease Treatment Market Share by Type (2015-2020)
Table 70. Southeast Asia Skin Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Skin Disease Treatment Market Share by Application (2015-2020)
Table 72. India Key Players Skin Disease Treatment Revenue (2019-2020) (Million US$)
Table 73. India Key Players Skin Disease Treatment Market Share (2019-2020)
Table 74. India Skin Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. India Skin Disease Treatment Market Share by Type (2015-2020)
Table 76. India Skin Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. India Skin Disease Treatment Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Skin Disease Treatment Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Skin Disease Treatment Market Share (2019-2020)
Table 80. Central & South America Skin Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Skin Disease Treatment Market Share by Type (2015-2020)
Table 82. Central & South America Skin Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Skin Disease Treatment Market Share by Application (2015-2020)
Table 84. APEIRON Biologics AG Company Details
Table 85. APEIRON Biologics AG Business Overview
Table 86. APEIRON Biologics AG Product
Table 87. APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 88. APEIRON Biologics AG Recent Development
Table 89. HanAll BioPharma Company Details
Table 90. HanAll BioPharma Business Overview
Table 91. HanAll BioPharma Product
Table 92. HanAll BioPharma Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 93. HanAll BioPharma Recent Development
Table 94. GlaxoSmithKline plc. Company Details
Table 95. GlaxoSmithKline plc. Business Overview
Table 96. GlaxoSmithKline plc. Product
Table 97. GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 98. GlaxoSmithKline plc. Recent Development
Table 99. Allergen, Plc. Company Details
Table 100. Allergen, Plc. Business Overview
Table 101. Allergen, Plc. Product
Table 102. Allergen, Plc. Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 103. Allergen, Plc. Recent Development
Table 104. Anacor Pharmaceuticals Company Details
Table 105. Anacor Pharmaceuticals Business Overview
Table 106. Anacor Pharmaceuticals Product
Table 107. Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 108. Anacor Pharmaceuticals Recent Development
Table 109. Celgene Company Details
Table 110. Celgene Business Overview
Table 111. Celgene Product
Table 112. Celgene Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 113. Celgene Recent Development
Table 114. Basilea Pharmaceutica Company Details
Table 115. Basilea Pharmaceutica Business Overview
Table 116. Basilea Pharmaceutica Product
Table 117. Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 118. Basilea Pharmaceutica Recent Development
Table 119. Cipher Pharmaceuticals Business Overview
Table 120. Cipher Pharmaceuticals Product
Table 121. Cipher Pharmaceuticals Company Details
Table 122. Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 123. Cipher Pharmaceuticals Recent Development
Table 124. Agenus Company Details
Table 125. Agenus Business Overview
Table 126. Agenus Product
Table 127. Agenus Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 128. Agenus Recent Development
Table 129. Astion Pharma A/S Company Details
Table 130. Astion Pharma A/S Business Overview
Table 131. Astion Pharma A/S Product
Table 132. Astion Pharma A/S Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 133. Astion Pharma A/S Recent Development
Table 134. Bristol-Myers Squibb Company Details
Table 135. Bristol-Myers Squibb Business Overview
Table 136. Bristol-Myers Squibb Product
Table 137. Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 138. Bristol-Myers Squibb Recent Development
Table 139. Almirall S.A. Company Details
Table 140. Almirall S.A. Business Overview
Table 141. Almirall S.A. Product
Table 142. Almirall S.A. Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 143. Almirall S.A. Recent Development
Table 144. Galderma Company Details
Table 145. Galderma Business Overview
Table 146. Galderma Product
Table 147. Galderma Revenue in Skin Disease Treatment Business (2015-2020) (Million US$)
Table 148. Galderma Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Skin Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Medicated Creams and Ointments Features
Figure 3. Antibiotics Features
Figure 4. Vitamins and Steroids Features
Figure 5. Antihistamines Features
Figure 6. Laser Therapy Features
Figure 7. Antifungals Features
Figure 8. Others Features
Figure 9. Global Skin Disease Treatment Market Share by Application: 2020 VS 2026
Figure 10. Dermatology Clinics Case Studies
Figure 11. Skincare Clinics Case Studies
Figure 12. Hospitals Case Studies
Figure 13. Aesthetic Centers Case Studies
Figure 14. Others Case Studies
Figure 15. Skin Disease Treatment Report Years Considered
Figure 16. Global Skin Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Skin Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 18. Global Skin Disease Treatment Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Skin Disease Treatment Market Share by Players in 2019
Figure 21. Global Top Skin Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Disease Treatment as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Skin Disease Treatment Revenue in 2019
Figure 23. North America Skin Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Skin Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Skin Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Skin Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Skin Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Skin Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Skin Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. APEIRON Biologics AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. APEIRON Biologics AG Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 32. HanAll BioPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. HanAll BioPharma Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 34. GlaxoSmithKline plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. GlaxoSmithKline plc. Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 36. Allergen, Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Allergen, Plc. Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 38. Anacor Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Anacor Pharmaceuticals Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 40. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Celgene Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 42. Basilea Pharmaceutica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Basilea Pharmaceutica Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 44. Cipher Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Cipher Pharmaceuticals Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 46. Agenus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Agenus Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 48. Astion Pharma A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Astion Pharma A/S Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 50. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 52. Almirall S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Almirall S.A. Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 54. Galderma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Galderma Revenue Growth Rate in Skin Disease Treatment Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed